Overview
Yiyun Fu practices practicing medicine in Chengdu, China.
Their clinical expertise encompasses Large-Cell Lung Carcinoma, Lung Cancer, EGFR Positive Lung Cancer, and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yiyun Fu
Is Yiyun Fu a top-rated expert for Large-Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Yiyun Fu is classified as an Experienced expert for Large-Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yiyun Fu participate in research or clinical trials?
Yes. Yiyun Fu has published 13 articles and abstracts on conditions like Large-Cell Lung Carcinoma. You can view a list of Yiyun Fu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung Cancer
- Langerhans Cell Histiocytosis
- Large-Cell Lung Carcinoma
- Lung AdenocarcinomaFu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerFu isExperienced. Learn about Lung Cancer.
- Neuroendocrine TumorFu isExperienced. Learn about Neuroendocrine Tumor.